Skip to main content
logo
Libo Pharma Corp. (TPEX:7888)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.90
-0.90 (-3.02%)
At close: Sep 2, 2026

Libo Pharma Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Market Capitalization
2,2123,702--
Market Cap Growth
----
Enterprise Value
1,5713,366--
Last Close Price
29.4049.20--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
PB Ratio
2.473.49--
P/TBV Ratio
2.924.06--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
0.000.000.010.04
Net Debt / Equity Ratio
-0.72-0.75-0.59-0.81
Net Debt / EBITDA Ratio
1.792.792.021.60
Net Debt / FCF Ratio
1.442.292.272.00
Quick Ratio
31.8937.4033.638.83
Current Ratio
38.2443.1935.399.12
Return on Equity (ROE)
-52.97%-39.01%-54.02%-
Return on Assets (ROA)
-32.74%-24.86%-33.29%-
Return on Capital Employed (ROCE)
-42.40%-29.10%-32.90%-53.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Earnings Yield
-16.42%-8.00%--
FCF Yield
-20.20%-9.45%--
Buyback Yield / Dilution
-34.43%-33.57%-76.69%-